|
(Health-NewsWire.Net, October 13, 2021 )
Market Overview
Immunosuppressant drugs are a class of drugs that suppress, or reduce, the strength of the body’s immune system. During organ transplantation, from a donor to a recipient, the immune system of the recipient gets stimulated and thus, produces an immune response like it does in response to other foreign material.
This immune response causes serious damage to the transplanted or grafted organ. It is often called rejection, which can be acute or chronic. This organ rejection is prohibited by using immunosuppressive drugs, which block the immune response and protect the new organ and its function.
View full report: https://bit.ly/3FGILgf
Market Dynamics
The global immunosuppressants drugs market growth is driven by innovations and advancements in organ transplantation procedures. The rise in the volume of these procedures is driving the growth of the market in the forecast period.
The increasing prevalence of diabetes is expected to drive the growth in the forecast period
An immunosuppressant is an agent that can suppress or prevent the immune response. Immunosuppressants drugs are used to prevent rejection of a transplanted organ and to treat autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (SLE), inflammatory bowel disease, Addison’s disease, and graves' disease among others. Commonly used immunosuppressants drugs include tacrolimus, cyclosporine A, glucocorticoids, methotrexate, and rituximab.
According to the 2017 report of the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number may rise to 629 million, globally.
Several government organizations and NGOs are working to increase awareness about the socioeconomic impact of autoimmunity through fostering and facilitating collaboration in the areas of education, public awareness, research, and patient services in an effective, ethical, and efficient manner. This factor will drive the growth of the market in the forecast period.
Market Segmentation:
By Drug Class
• Calcineurin Inhibitors
• Antiproliferative Agents
• mTOR Inhibitor
By Indication
• Organ Transplantation
• Autoimmune Disorders
• Non-Autoimmune Inflammatory Diseases
By Distribution Channel
• Hospital Pharmacy
• Pharmacy Stores
Download free sample: https://bit.ly/3iWThGk
Geographical Analysis
North America region holds the largest market share global immunosuppressants drugs market
North America is expected to hold a major market share in the global immunosuppressant drugs market due to the increasing prevalence of autoimmune diseases and the rapid rise in the number of organ transplants in this region.
According to the Centers for Disease Control (CDC), in the year 2017, it was estimated that approximately 19 percent of men and 25 percent of women in the United States had doctor-diagnosed arthritis, in addition, doctor-diagnosed arthritis was prevalent in 16.4 percent of people who were underweight, while 27.7 percent of individuals who were obese.
Furthermore, technological advancements in tissue engineering and organ transplantations, increasing healthcare spending coupled with increasing investments in research and development, and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.
Drug classes such as CETP inhibitors have been withdrawn or discontinued even in the later stages of trials due to adverse effects or failure to achieve satisfactory results. Risks associated with immunosuppressants pose a major challenge to their entry into the market.
Competitive Landscape
The immunosuppressants drugs market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Astellas Pharma, Inc, Sanofi (Genzyme), Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc, GlaxoSmithKline Plc, Allergan Plc, Accord Healthcare Ltd, and Mylan Laboratories, Inc. among others.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the immunosuppressants drugs market globally.
Related Topic's
Autoimmune Treatment Market, Allergy Immunotherapies Market, Thrombocytopenia Management Market, Systemic Lupus Erythematosus Market, Systemic Sclerosis Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
